Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19
V Maldonado, MA Loza-Mejia, J Chavez-Alderete - Medical hypotheses, 2020 - Elsevier
Pentoxifylline (PTX) is a phosphodiesterase inhibitor that increases cyclic adenosine
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19.
V Maldonado, MA Loza-Mejía, J Chávez-Alderete - 2020 - cabidigitallibrary.org
Pentoxifylline (PTX) is a phosphodiesterase inhibitor that increases cyclic adenosine
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
[PDF][PDF] Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19
V Maldonado, MA Loza-Mejía… - Medical …, 2020 - 96.95.217.100
Pentoxifylline (PTX) is a phosphodiesterase inhibitor that increases cyclic adenosine
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
[HTML][HTML] Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19
V Maldonado, MA Loza-Mejía… - Medical …, 2020 - ncbi.nlm.nih.gov
Pentoxifylline (PTX) is a phosphodiesterase inhibitor that increases cyclic adenosine
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19
V Maldonado, MA Loza-Mejía… - 2020 - expeditiorepositorio.utadeo.edu.co
Pentoxifylline (PTX) is a phosphodiesterase inhibitor that increases cyclic adenosine
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19.
V Maldonado, MA Loza-Mejía… - Medical …, 2020 - europepmc.org
Pentoxifylline (PTX) is a phosphodiesterase inhibitor that increases cyclic adenosine
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19
V Maldonado, MA Loza-Mejía… - Medical …, 2020 - pubmed.ncbi.nlm.nih.gov
Pentoxifylline (PTX) is a phosphodiesterase inhibitor that increases cyclic adenosine
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …
monophosphate levels, which in turn activate protein kinase, leading to a reduction in the …